| Use of postmenopausal hormones and risk of myocardial infarction. | |
| | |
MedLine Citation:
|
PMID: 7237723 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Information was collected by mail survey about myocardial infarction (MI), use of female hormones after menopause, and coronary risk factors 121,964 registered nurses ages 30-55 years. One hundred twenty-three women with a known type of prior menopause reported hospitalization for MI. Overall, use of female hormones by these women was very similar to that of control women matched for age and type of menopause. Compared with nonusers, the relative risk (RR) for women who had ever taken female hormones was 0.9 (95% confidence limits 0.6-1.2), and for current users the RR was 0.7 (0.5-1.1). For women with bilateral oophorectomy, the RR for current users was 0.4 (0.2-0.8). These data imply that, at present, a decision to prescribe postmenopausal hormones should be based primarily on weighing possible benefits from the relief of menopausal symptoms against unknown or suspected risks of other diseases, particularly uterine cancer in women with an intact uterus. |
| | |
Authors:
|
C Bain; W Willett; C H Hennekens; B Rosner; C Belanger; F E Speizer |
Related Documents
:
|
17429333 - Does menopausal transition affect the quality of life? a longitudinal study of middle-a... 19091633 - Management of premature ovarian failure. 19860303 - End-of-treatment smoking cessation among african american female participants in the br... |
Publication Detail:
|
Type: Journal Article; Research Support, U.S. Gov't, P.H.S. |
Journal Detail:
|
Title: Circulation Volume: 64 ISSN: 0009-7322 ISO Abbreviation: Circulation Publication Date: 1981 Jul |
Date Detail:
|
Created Date: 1981-08-10 Completed Date: 1981-08-10 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 0147763 Medline TA: Circulation Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 42-6 Citation Subset: AIM; IM |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Estrogens / adverse effects, therapeutic use* Female Humans Menopause* Middle Aged Myocardial Infarction / etiology* Ovary / surgery Risk Smoking Time Factors |
| Grant Support | |
ID/Acronym/Agency:
|
CA 16886/CA/NCI NIH HHS; CA 23645/CA/NCI NIH HHS; HL 24074/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/Estrogens |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of myocardial infarction on high-frequency QRS potentials.
Next Document: Detection of residual myocardial function in acute transmural infarction using postextrasystolic pot...